Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses
2018 · Nature Communications · 59 citations
https://doi.org/10.1038/s41467-018-05062-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
204
Citations
7
h-index
5
i10-index
Lingmiao Kong is an academic researcher. The author has contributed to research in topics: Neuropeptides and Animal Physiology & Chemokine receptors and signaling & Angiogenesis and VEGF in Cancer. The author has an h-index of 7, co-authored 17 publications.
https://doi.org/10.1038/s41467-018-05062-2
https://doi.org/10.1016/j.asjsur.2025.10.024
Click to start Chat